Glenwood Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2018
- Revenue -47.29%
(FY 2017)
- Profit 208.15%
(FY 2017)
- Ebitda -41.26%
(FY 2017)
- Net Worth 3.54%
(FY 2017)
- Total Assets 2.14%
(FY 2017)
About Glenwood Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Venkata Vallamkonda, Vuttaradi Rao, Prakashrao Dannina, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24303AP2012PTC078648
- Company No.
078648
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2012
- Date of AGM
28 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Glenwood Biotech Private Limited offer?
Glenwood Biotech Private Limited offers a wide range of products and services, including Health Conditions, Heart Care.
Who are the key members and board of directors at Glenwood Biotech?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Vallamkonda  | Director | 07-Mar-2015 | Current |
| Vuttaradi Rao | Director | 19-Jan-2012 | Current |
| Prakashrao Dannina | Director | 19-Jan-2012 | Current |
| Nagadurga Samudrala | Director | 19-Jan-2012 | Current |
| Sudharani Vallamkonda | Director | 07-Mar-2015 | Current |
Financial Performance of Glenwood Biotech.
Glenwood Biotech Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 47.29% decrease. The company also saw a substantial improvement in profitability, with a 208.15% increase in profit. The company's net worth moved up by a moderate rise of 3.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glenwood Biotech?
In 2017, Glenwood Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Century Pharmalabs India Private LimitedActive 11 years 5 monthsVenkata Vallamkonda is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Glenwood Biotech?
Unlock and access historical data on people associated with Glenwood Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glenwood Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glenwood Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
